Detalles de la búsqueda
1.
Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
J Immunol
; 208(5): 1139-1145, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101893
2.
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
Lancet
; 397(10275): 671-681, 2021 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545094
3.
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
Lancet
; 396(10255): 887-897, 2020 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32896291
4.
Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma.
Vox Sang
; 116(6): 665-672, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33734455
5.
Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
Lancet
; 397(10288): 1883-1884, 2021 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991474
6.
Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
Lancet
; 396(10256): e54-e55, 2020 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32971043
7.
Combined stimulation of Toll-like receptor 5 and NOD1 strongly potentiates activity of NF-κB, resulting in enhanced innate immune reactions and resistance to Salmonella enterica serovar Typhimurium infection.
Infect Immun
; 81(10): 3855-64, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23897616
8.
Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period.
Front Immunol
; 14: 1259725, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37928549
9.
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A.
Front Immunol
; 14: 1098302, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865543
10.
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19.
Front Immunol
; 14: 1129245, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063833
11.
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.
Front Immunol
; 14: 1228461, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37600800
12.
Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy.
EClinicalMedicine
; 46: 101360, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35340627
13.
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis.
Front Microbiol
; 13: 960937, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36238585
14.
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection.
Viruses
; 14(11)2022 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366583
15.
Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level.
Vaccines (Basel)
; 11(1)2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36679936
16.
Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals.
Vaccines (Basel)
; 10(5)2022 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35632574
17.
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
Front Immunol
; 13: 822159, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35281053
18.
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates.
Emerg Microbes Infect
; 11(1): 2229-2247, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031930
19.
Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus.
Front Immunol
; 13: 1023164, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36466896
20.
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.
Lancet Reg Health Eur
; 11: 100241, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34746910